Medicare Enrolled

Dr. Ashley Ross

Urology Physician · Chicago, IL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
675 N SAINT CLAIR ST STE 20-150, Chicago, IL 60611
3126958146
In practice since 2007 (19 years)
NPI: 1891840641 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ross from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ross? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ross

Dr. Ashley Ross is an urology physician in Chicago, IL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Ross performed 1,467 Medicare services across 1,184 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ross received a total of $376,856 from 39 pharmaceutical and/or device companies across 411 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ross is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 1,467 Medicare services $376,856 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,467
Medicare services
Bottom 45% in IL for urology physician
1,184
Unique beneficiaries
$106
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~77 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
227 $62 $175
Leuprolide acetate (for depot suspension), 7.5 mg 170 $131 $2,712
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
161 $89 $323
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
140 $87 $250
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
113 $130 $434
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
108 $187 $1,357
Transrectal ultrasound of the pelvis
An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures.
102 $112 $706
3D radiographic procedure with computerized image postprocessing
A radiographic imaging procedure that creates three-dimensional images using computerized processing of the captured data.
88 $62 $932
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
67 $8 $20
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
58 $101 $506
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
49 $60 $219
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
46 $28 $237
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
41 $7 $230
New patient office visit, complex (60-74 min) 36 $181 $625
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
17 $185 $1,163
Surgical removal of prostate and lymph nodes
This procedure involves the surgical removal of the prostate gland and surrounding lymph nodes using an endoscope.
15 $975 $9,117
Ultrasound guidance for needle placement
Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure.
15 $49 $893
Endoscopic removal of pelvic lymph nodes, bilateral
A surgical procedure to remove lymph nodes from both sides of the pelvis using an endoscope. This minimally invasive technique involves making small incisions to access and excise the tissue.
14 $284 $4,233
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$376,856
Total received (2018-2024)
Avg $53,837/year across 7 years
Top 1% in IL for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
411
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$256,203 (68.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$117,469 (31.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,185 (0.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$53,397
2023
$86,649
2022
$96,237
2021
$66,087
2020
$38,128
2019
$24,931
2018
$11,429

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$17,282
PROGENICS PHARMACEUTICALS, INC.
$16,403
Astellas Pharma US Inc
$5,347
Blue Earth Diagnostics Limited
$4,706
Boston Scientific Corporation
$3,900
Novartis Pharmaceuticals Corporation
$2,100
Astellas Pharma Global Development
$1,755
PFIZER INC.
$1,419
Sumitomo Pharma America, Inc.
$292
AngioDynamics, Inc.
$172
Janssen Scientific Affairs, LLC
$21
Top 3 companies account for 73.1% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$85,375
Progenics Pharmaceuticals, Inc.
$49,400
Blue Earth Diagnostics Limited
$40,025
Astellas Pharma US Inc
$31,368
PFIZER INC.
$27,192
Bayer HealthCare Pharmaceuticals Inc.
$24,381
Astellas Pharma Global Development
$23,957
Myovant Sciences Inc.
$20,346
Bayer Healthcare Pharmaceuticals Inc.
$19,012
PROGENICS PHARMACEUTICALS, INC.
$16,403
Sumitomo Pharma America, Inc.
$12,800
Janssen Scientific Affairs, LLC
$5,196
Intuitive Surgical, Inc.
$5,169
Boston Scientific Corporation
$4,074
NOVARTIS PHARMACEUTICALS CORPORATION
$2,400
AbbVie Inc.
$2,125
Novartis Pharmaceuticals Corporation
$2,100
Janssen Research & Development, LLC
$1,790
Daiichi Sankyo Inc.
$1,410
Dendreon Pharmaceuticals LLC
$986
AstraZeneca Pharmaceuticals LP
$318
AngioDynamics, Inc.
$172
TOLMAR Pharmaceuticals, Inc.
$102
ABBVIE INC.
$102
Janssen Products, LP
$100
Sun Pharmaceutical Industries Inc.
$83
BK Medical Holding Company Inc.
$79
EDAP TECHNOMED INC
$77
AbbVie, Inc.
$64
Agiliti Surgical, Inc.
$50
Ferring Pharmaceuticals Inc.
$49
BOSTON SCIENTIFIC CORPORATION
$38
DENTSPLY IH Inc.
$23
GENZYME CORPORATION
$21
Coloplast Corp
$19
Antares Pharma, Inc.
$13
ROCHESTER MEDICAL CORPORATION
$12
Merck Sharp & Dohme Corporation
$12
C. R. BARD, INC. & SUBSIDIARIES
$11
Top 3 companies account for 46.4% of all-time payments
Associated products mentioned in payments ›
Axumin · Da Vinci Surgical System · ELIGARD · ERLEADA · Erleada · FIRMAGON · GENERAL THERAPIES · GENERAL - BPH · HUMIRA · JEVTANA · KEYTRUDA · LUPRON DEPOT · LUTATHERA · LYNPARZA · LoFric · Lupron · Lupron Depot · MYRBETRIQ · NANOKNIFE · NOCDURNA · Non-Covered · Nubeqa · ORGOVYX · POSLUMA · PROVENGE · PYLARIFY · SPACEOAR VUE · SpaceOAR VUE System - 10mL · SpeediCath · TALZENNA · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · YONSA (abiraterone acetate) · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (68%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for urology physician in IL.

Looking for an urology physician in Chicago?
Compare urology physicians in the Chicago area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
311
Per 100K population
6.0
County median income
$81,797
Nearest hospital
NORTHWESTERN MEMORIAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Ross is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 1% of IL peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Ross experienced with telephone medical discussion, 11-20 minutes?
Based on Medicare claims data, Dr. Ross performed 227 telephone medical discussion, 11-20 minutes services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ross receive payments from pharmaceutical companies?
Yes. Dr. Ross received a total of $376,856 from 39 companies across 411 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ross's costs compare to other urology physicians in Chicago?
Dr. Ross's average Medicare payment per service is $106. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ross) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →